Fuping Chen sold $4.0M of ACMR
See remarks at ACM Research, Inc.. 120,000 shares at an average of $33.18, traded Dec 2, 2025, filed Dec 4, 2025.
Score components
- +15RoleOfficer
- +25Trade size$4.0M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +29.6%, 3m +39.5%, 6m +160.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-044360, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2025 | MOption exercise Class A Common Stock10b5-1 | +100,000 | $1.77 | $177k | 100,000 | Dec 4, 2025 |
| Dec 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $33.20 | $3.3M | 0 | Dec 4, 2025 |
| Dec 3, 2025 | MOption exercise Class A Common Stock10b5-1 | +20,000 | $1.77 | $35k | 20,000 | Dec 4, 2025 |
| Dec 3, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -19,700 | $33.05 | $651k | 300 | Dec 4, 2025 |
| Dec 3, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -300 | $33.57 | $10k | 0 | Dec 4, 2025 |
| Dec 2, 2025 | MOption exercise Stock Optionderivative10b5-1 | -100,000 | $0.00 | $0 | 41,165 | Dec 4, 2025 |
| Dec 3, 2025 | MOption exercise Stock Optionderivative10b5-1 | -20,000 | $0.00 | $0 | 21,165 | Dec 4, 2025 |
Related signals
Other insiders at ACM Research, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | ACM Research, Inc. | David H Wang See Remarks | $11M 140,000 shares | -16% | |
| 33Weak | ACM Research, Inc. | Mark McKechnie See Remarks | $4.3M 55,199 shares | -98% | |
| 24Weak | ACM Research, Inc. | Haiping Dun director | $406k 5,000 shares | -100% | |
| 18Weak | ACM Research, Inc. | David H Wang See Remarks | $8.8M 100,002 shares | -12% | |
| 18Weak | ACM Research, Inc. | Sotheara Cheav See remarks | $1.6M 18,750 shares | -17% | |
| 15Weak | ACM Research, Inc. | Haiping Dun director | $331k 5,000 shares | -100% | |
| 13Weak | ACM Research, Inc. | Charles C Pappis director | $260k 5,000 shares | -100% | |
| 25Weak | ACM Research, Inc. | David H Wang See Remarks | $5.2M 110,000 shares | -13% | |
| 40Moderate | ACM Research, Inc. | Mark McKechnie See Remarks | $4.5M 98,551 shares | -162% | |
| 30Weak | ACM Research, Inc. | Tracy Liu director | $2.9M 60,000 shares | -39% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.